Index NDX, S&P 500
P/E -
EPS (ttm) -8.15
Insider Own 0.50%
Shs Outstand 159.00M
Perf Week -3.56%
Market Cap 18.74B
Forward P/E 46.29
EPS next Y 2.55
Insider Trans 0.89%
Shs Float 158.10M
Perf Month -6.40%
Income -1290.00M
PEG -
EPS next Q 0.09
Inst Own 93.63%
Short Float 3.34%
Perf Quarter -18.22%
Sales 4.49B
P/S 4.17
EPS this Y -9.54%
Inst Trans 2.72%
Short Ratio 3.25
Perf Half Y 10.57%
Book/sh 36.13
P/B 3.26
EPS next Y 227.48%
ROA -11.81%
Short Interest 5.27M
Perf Year -40.00%
Cash/sh 6.97
P/C 16.91
EPS next 5Y 22.90%
ROE -20.76%
52W Range 89.00 - 213.91
Perf YTD -15.30%
Dividend Est. -
P/FCF 66.45
EPS past 5Y -
ROI -16.28%
52W High -44.87%
Beta 1.24
Dividend TTM -
Quick Ratio 1.36
Sales past 5Y 7.40%
Gross Margin 69.64%
52W Low 32.51%
ATR (14) 5.03
Dividend Ex-Date -
Current Ratio 1.75
EPS Y/Y TTM 71.48%
Oper. Margin -1.18%
RSI (14) 38.53
Volatility 4.21% 3.82%
Employees 12010
Debt/Eq 0.38
Sales Y/Y TTM 1.03%
Profit Margin -28.71%
Recom 2.46
Target Price 151.55
Option/Short Yes / Yes
LT Debt/Eq 0.38
EPS Q/Q -4270.53%
Payout -
Rel Volume 1.82
Prev Close 123.99
Sales Surprise 2.44%
EPS Surprise 109.79%
Sales Q/Q -1.01%
Earnings May 02 AMC
Avg Volume 1.62M
Price 117.93
SMA20 -4.86%
SMA50 -9.49%
SMA200 -14.16%
Trades
Volume 2,958,574
Change -4.89%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-16-24 Downgrade
HSBC Securities
Buy → Hold
Jan-04-24 Downgrade
TD Cowen
Outperform → Market Perform
$144
Dec-18-23 Upgrade
Scotiabank
Sector Perform → Sector Outperform
$185
Dec-15-23 Upgrade
Bernstein
Underperform → Mkt Perform
Dec-14-23 Initiated
Stephens
Overweight
$170
Dec-14-23 Initiated
Guggenheim
Buy
$155
Dec-13-23 Initiated
Wolfe Research
Outperform
$175
Dec-12-23 Downgrade
BofA Securities
Neutral → Underperform
$140 → $100
Dec-11-23 Upgrade
Citigroup
Sell → Neutral
$85 → $120
Nov-10-23 Downgrade
Canaccord Genuity
Buy → Hold
$210 → $120
Sep-28-23 Initiated
Bernstein
Underperform
$111
Jul-05-23 Resumed
JP Morgan
Neutral
$235
Jan-25-23 Downgrade
Argus
Buy → Hold
Jan-05-23 Initiated
Scotiabank
Sector Perform
$216
Dec-12-22 Downgrade
Citigroup
Neutral → Sell
$200 → $180
Dec-07-22 Initiated
RBC Capital Mkts
Outperform
$282
Oct-04-22 Upgrade
SVB Leerink
Mkt Perform → Outperform
$220 → $270
Sep-28-22 Upgrade
Evercore ISI
In-line → Outperform
$170 → $250
Aug-25-22 Initiated
Credit Suisse
Neutral
$230
Jul-13-22 Downgrade
Barclays
Equal Weight → Underweight
$350 → $150
Show Previous Ratings
Today 11:55AM
10:46AM
10:46AM
10:20AM
09:39AM
09:25AM
Loading…
09:25AM
09:18AM
07:16AM
(Thomson Reuters StreetEvents)
06:55AM
04:12AM
May-02-24 09:46PM
08:56PM
07:30PM
06:25PM
05:35PM
05:21PM
Loading…
05:21PM
04:17PM
(Associated Press Finance)
04:05PM
06:04AM
Apr-29-24 09:09PM
12:45PM
09:16AM
Apr-26-24 06:03AM
Apr-25-24 10:02AM
08:53AM
Apr-21-24 08:30AM
Apr-19-24 02:05PM
12:10PM
Apr-18-24 01:30PM
08:00AM
09:30AM
Loading…
Apr-17-24 09:30AM
Apr-15-24 05:40AM
Apr-12-24 09:00AM
06:21AM
05:49AM
Apr-10-24 08:16AM
Apr-09-24 11:37PM
05:28PM
04:32PM
04:28PM
04:18PM
04:05PM
Apr-05-24 02:27PM
12:45PM
Apr-04-24 05:00PM
Apr-02-24 09:45AM
Mar-30-24 07:43PM
Mar-26-24 08:02AM
Mar-25-24 06:17AM
Mar-21-24 06:37PM
05:44AM
05:12AM
05:01AM
Mar-18-24 12:40PM
Mar-17-24 08:50AM
Mar-14-24 07:42PM
Mar-13-24 06:43AM
Mar-12-24 04:50PM
02:41PM
01:57PM
Mar-08-24 08:45AM
Mar-07-24 03:00PM
08:45AM
Mar-02-24 02:30PM
Feb-28-24 05:52AM
Feb-27-24 03:40AM
03:09AM
Feb-26-24 06:29PM
11:00AM
Feb-24-24 06:50AM
Feb-23-24 07:59AM
Feb-21-24 07:42PM
09:00AM
Feb-20-24 10:25AM
Feb-14-24 07:00PM
09:40AM
Feb-09-24 11:19AM
07:52AM
(Thomson Reuters StreetEvents)
07:39AM
05:45AM
01:32AM
Feb-08-24 06:30PM
05:24PM
04:34PM
04:24PM
(Associated Press Finance)
04:05PM
09:14AM
Feb-05-24 09:16AM
Feb-01-24 09:10PM
Jan-30-24 07:31AM
Jan-29-24 07:49PM
Jan-28-24 09:25AM
Jan-23-24 08:45PM
Jan-19-24 08:25AM
Jan-18-24 07:52AM
05:04AM
Jan-17-24 12:04PM
Jan-16-24 10:11AM
Jan-15-24 07:00AM
Jan-12-24 09:45AM
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Thaysen Jacob Chief Executive Officer Feb 22 '24 Buy 135.29 7,330 991,672 14,861 Feb 26 08:57 AM Hoyt Aimee L SVP, Chief People Officer Nov 07 '23 Sale 112.84 315 35,545 8,314 Nov 09 04:22 PM TOUSI SUSAN H SVP, Chief Commercial Officer Aug 22 '23 Sale 167.04 500 83,520 45,524 Aug 24 04:19 PM TOUSI SUSAN H SVP, Chief Commercial Officer Jul 24 '23 Sale 190.08 500 95,040 46,022 Jul 26 06:14 PM TOUSI SUSAN H SVP, Chief Commercial Officer Jun 22 '23 Sale 200.00 500 100,000 46,522 Jun 26 05:23 PM EPSTEIN ROBERT S Director May 25 '23 Option Exercise 71.09 7,600 540,284 14,764 May 25 04:34 PM
Index S&P 500
P/E 36.64
EPS (ttm) 2.33
Insider Own 1.58%
Shs Outstand 601.10M
Perf Week -1.37%
Market Cap 51.37B
Forward P/E 27.38
EPS next Y 3.11
Insider Trans -4.63%
Shs Float 593.08M
Perf Month -6.52%
Income 1.41B
PEG 3.93
EPS next Q 0.70
Inst Own 82.56%
Short Float 1.24%
Perf Quarter -0.98%
Sales 6.14B
P/S 8.36
EPS this Y 10.39%
Inst Trans -0.08%
Short Ratio 1.96
Perf Half Y 33.56%
Book/sh 11.82
P/B 7.21
EPS next Y 12.38%
ROA 15.38%
Short Interest 7.38M
Perf Year -3.23%
Cash/sh 2.82
P/C 30.20
EPS next 5Y 9.34%
ROE 21.59%
52W Range 60.57 - 96.12
Perf YTD 11.80%
Dividend Est. -
P/FCF 189.28
EPS past 5Y 15.35%
ROI 18.14%
52W High -11.31%
Beta 1.12
Dividend TTM -
Quick Ratio 2.67
Sales past 5Y 10.28%
Gross Margin 76.11%
52W Low 40.75%
ATR (14) 2.07
Dividend Ex-Date -
Current Ratio 3.75
EPS Y/Y TTM -3.43%
Oper. Margin 27.71%
RSI (14) 38.07
Volatility 2.30% 2.25%
Employees 19800
Debt/Eq 0.10
Sales Y/Y TTM 11.68%
Profit Margin 23.01%
Recom 2.12
Target Price 95.95
Option/Short Yes / Yes
LT Debt/Eq 0.09
EPS Q/Q 4.50%
Payout 0.00%
Rel Volume 0.61
Prev Close 85.06
Sales Surprise 1.80%
EPS Surprise 2.66%
Sales Q/Q 9.50%
Earnings Apr 25 AMC
Avg Volume 3.76M
Price 85.25
SMA20 -3.56%
SMA50 -5.25%
SMA200 8.60%
Trades
Volume 2,294,544
Change 0.22%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-07-24 Upgrade
BofA Securities
Neutral → Buy
Feb-02-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$94
Jan-04-24 Downgrade
Evercore ISI
Outperform → In-line
$80 → $77
Dec-11-23 Downgrade
Citigroup
Buy → Neutral
Nov-28-23 Downgrade
Wolfe Research
Peer Perform → Underperform
$57
Sep-26-23 Upgrade
Oppenheimer
Perform → Outperform
$90
Jul-19-23 Initiated
Robert W. Baird
Outperform
$107
May-30-23 Resumed
Morgan Stanley
Overweight
$102
Mar-29-23 Initiated
UBS
Neutral
$84
Mar-08-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$97 → $78
Feb-06-23 Downgrade
Raymond James
Outperform → Mkt Perform
Jan-31-23 Downgrade
Bernstein
Outperform → Underperform
$95 → $66
Jan-30-23 Downgrade
Piper Sandler
Overweight → Neutral
$95 → $80
Dec-06-22 Downgrade
Stifel
Buy → Hold
$95 → $75
Oct-28-22 Downgrade
Oppenheimer
Outperform → Perform
Oct-26-22 Initiated
Mizuho
Buy
$100
Oct-18-22 Initiated
Barclays
Overweight
$96
Oct-12-22 Initiated
Jefferies
Buy
$110
Jul-29-22 Downgrade
Canaccord Genuity
Buy → Hold
$115 → $106
Apr-13-22 Initiated
Truist
Buy
$145
Show Previous Ratings
May-01-24 05:27PM
09:40AM
09:35AM
Apr-30-24 05:03PM
10:20AM
02:22PM
Loading…
Apr-29-24 02:22PM
12:18PM
07:23AM
Apr-26-24 04:09PM
(Investor's Business Daily)
11:21AM
11:09AM
10:54AM
10:42AM
10:38AM
(Thomson Reuters StreetEvents)
10:29AM
09:53AM
Loading…
09:53AM
08:28AM
03:40AM
Apr-25-24 06:00PM
05:52PM
05:30PM
05:04PM
(Investor's Business Daily)
04:34PM
04:26PM
(Associated Press Finance)
04:15PM
Apr-23-24 06:14AM
Apr-22-24 09:16AM
Apr-19-24 01:08AM
Apr-18-24 10:01AM
07:10AM
11:01AM
Loading…
Apr-17-24 11:01AM
Apr-12-24 04:37AM
Apr-07-24 04:30PM
Mar-26-24 08:02AM
Mar-25-24 09:40AM
Mar-19-24 02:24PM
(Investor's Business Daily)
01:38PM
Mar-15-24 04:02PM
10:50AM
Mar-13-24 11:57AM
Mar-11-24 02:00PM
Mar-07-24 04:57PM
11:31AM
Mar-06-24 09:43AM
Feb-26-24 11:54AM
Feb-23-24 07:05AM
Feb-18-24 01:26PM
Feb-15-24 09:36AM
Feb-13-24 12:09AM
Feb-09-24 02:21AM
Feb-07-24 04:11PM
(Investor's Business Daily)
11:19AM
10:31AM
09:06AM
(Thomson Reuters StreetEvents)
05:54AM
Feb-06-24 07:55PM
06:00PM
05:25PM
04:54PM
04:44PM
(Investor's Business Daily)
04:40PM
(Associated Press Finance)
04:15PM
07:18AM
Feb-02-24 07:00AM
06:27AM
Feb-01-24 09:15AM
07:44AM
Jan-30-24 07:05AM
06:15AM
Jan-23-24 07:07AM
Jan-19-24 11:26AM
Jan-16-24 01:20AM
Jan-03-24 07:40AM
Jan-02-24 09:00AM
Dec-20-23 05:24AM
Dec-14-23 07:49PM
Dec-11-23 12:27PM
Dec-08-23 05:11AM
Dec-07-23 05:00PM
08:30AM
Nov-26-23 05:56AM
Nov-25-23 06:58AM
Nov-24-23 11:31AM
Nov-23-23 06:06AM
Oct-30-23 11:40AM
Oct-27-23 07:30AM
Oct-26-23 06:15PM
03:06PM
02:00PM
11:33AM
11:17AM
11:12AM
10:08AM
07:23AM
07:20AM
(Thomson Reuters StreetEvents)
Oct-25-23 06:00PM
06:00PM
05:40PM
04:32PM
(Associated Press Finance)
04:15PM
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MUSSALLEM MICHAEL A Director May 02 '24 Option Exercise 36.75 29,350 1,078,612 33,836 May 02 06:05 PM MUSSALLEM MICHAEL A Director May 02 '24 Sale 84.77 29,350 2,487,966 4,486 May 02 06:05 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC May 01 '24 Option Exercise 36.75 14,400 529,200 188,249 May 01 05:17 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC May 01 '24 Sale 84.21 14,400 1,212,687 173,849 May 01 05:17 PM Ullem Scott B. CVP, Chief Financial Officer Apr 30 '24 Option Exercise 36.75 7,250 266,438 26,324 Apr 30 04:56 PM Ullem Scott B. CVP, Chief Financial Officer Apr 30 '24 Sale 85.80 7,250 622,062 19,074 Apr 30 04:56 PM Lippis Daniel J. CVP, JAPAC Apr 09 '24 Option Exercise 36.75 857 31,495 18,345 Apr 09 05:33 PM Lippis Daniel J. CVP, JAPAC Apr 09 '24 Sale 92.34 857 79,135 17,488 Apr 09 05:33 PM Lemercier Jean-Luc M CVP, EMEACLA Apr 08 '24 Option Exercise 36.75 14,400 529,200 188,249 Apr 08 05:10 PM BOBO DONALD E JR CVP,Strategy/Corp Development Apr 08 '24 Option Exercise 36.75 12,500 459,375 52,268 Apr 08 05:10 PM Lemercier Jean-Luc M CVP, EMEACLA Apr 08 '24 Sale 92.32 14,400 1,329,472 173,849 Apr 08 05:10 PM BOBO DONALD E JR CVP,Strategy/Corp Development Apr 08 '24 Sale 92.33 12,500 1,154,142 39,768 Apr 08 05:10 PM MUSSALLEM MICHAEL A Director Apr 04 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Apr 04 06:26 PM MUSSALLEM MICHAEL A Director Apr 04 '24 Sale 92.42 29,350 2,712,418 4,486 Apr 04 06:26 PM Ullem Scott B. CVP, Chief Financial Officer Apr 01 '24 Option Exercise 36.75 7,255 266,621 26,329 Apr 01 06:55 PM Ullem Scott B. CVP, Chief Financial Officer Apr 01 '24 Sale 94.89 7,255 688,423 19,074 Apr 01 06:55 PM BOBO DONALD E JR CVP,Strategy/Corp Development Mar 13 '24 Option Exercise 36.75 14,500 532,875 54,003 Mar 13 05:44 PM BOBO DONALD E JR CVP,Strategy/Corp Development Mar 13 '24 Sale 91.01 14,500 1,319,696 39,503 Mar 13 05:44 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC Mar 11 '24 Option Exercise 36.75 14,400 529,200 187,984 Mar 11 06:00 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC Mar 11 '24 Sale 91.68 14,400 1,320,149 173,584 Mar 11 06:00 PM Lippis Daniel J. CVP, JAPAC Mar 07 '24 Option Exercise 36.75 1,715 63,026 18,928 Mar 07 06:22 PM Lippis Daniel J. CVP, JAPAC Mar 07 '24 Sale 90.98 1,715 156,031 17,213 Mar 07 06:22 PM MUSSALLEM MICHAEL A Director Mar 04 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Mar 04 07:16 PM MUSSALLEM MICHAEL A Director Mar 04 '24 Sale 86.67 29,350 2,543,737 4,486 Mar 04 07:16 PM Ullem Scott B. CVP, Chief Financial Officer Feb 29 '24 Option Exercise 36.75 7,255 266,621 26,329 Feb 29 05:12 PM Ullem Scott B. CVP, Chief Financial Officer Feb 29 '24 Sale 85.59 7,255 620,923 19,074 Feb 29 05:12 PM GALLAHUE KIERAN Director Feb 23 '24 Option Exercise 36.86 7,056 260,107 10,757 Feb 26 05:52 PM GALLAHUE KIERAN Director Feb 23 '24 Sale 87.61 3,058 267,911 67,219 Feb 26 05:52 PM Chopra Daveen CVP, TMTT Feb 21 '24 Option Exercise 59.26 7,000 414,797 30,950 Feb 21 05:52 PM Chopra Daveen CVP, TMTT Feb 21 '24 Sale 86.74 8,200 711,272 22,750 Feb 21 05:52 PM Szyman Catherine M. CVP, Critical Care Feb 15 '24 Option Exercise 36.75 27,000 992,250 61,814 Feb 15 05:25 PM Szyman Catherine M. CVP, Critical Care Feb 15 '24 Sale 85.62 27,000 2,311,654 34,814 Feb 15 05:25 PM Szyman Catherine M. CVP, Critical Care Feb 13 '24 Option Exercise 36.75 20,000 735,000 54,814 Feb 15 05:25 PM BOBO DONALD E JR CVP,Strategy/Corp Development Feb 13 '24 Option Exercise 36.75 11,000 404,250 50,503 Feb 13 04:51 PM Szyman Catherine M. CVP, Critical Care Feb 13 '24 Sale 86.46 20,000 1,729,200 34,814 Feb 15 05:25 PM BOBO DONALD E JR CVP,Strategy/Corp Development Feb 13 '24 Sale 85.83 11,000 944,155 39,503 Feb 13 04:51 PM SELLERS ROBERT W.A. SVP, Corporate Controller Feb 12 '24 Option Exercise 36.75 12,210 448,718 25,297 Feb 12 05:44 PM SELLERS ROBERT W.A. SVP, Corporate Controller Feb 12 '24 Sale 87.00 12,210 1,062,270 13,087 Feb 12 05:44 PM STONE HEISZ LESLIE Director Feb 08 '24 Option Exercise 36.86 7,056 260,107 34,036 Feb 08 06:08 PM STONE HEISZ LESLIE Director Feb 08 '24 Sale 86.45 7,056 609,991 26,980 Feb 08 06:08 PM MUSSALLEM MICHAEL A Director Feb 05 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Feb 05 06:37 PM MUSSALLEM MICHAEL A Director Feb 05 '24 Sale 87.49 29,350 2,567,754 4,486 Feb 05 06:37 PM Ullem Scott B. CVP, Chief Financial Officer Feb 01 '24 Option Exercise 36.75 7,255 266,621 26,503 Feb 01 05:52 PM Ullem Scott B. CVP, Chief Financial Officer Feb 01 '24 Sale 78.29 7,255 567,994 19,248 Feb 01 05:52 PM BOBO DONALD E JR CVP,Strategy/Corp Development Jan 12 '24 Option Exercise 36.75 10,000 367,500 49,503 Jan 12 05:36 PM BOBO DONALD E JR CVP,Strategy/Corp Development Jan 12 '24 Sale 75.67 10,000 756,700 39,503 Jan 12 05:36 PM MUSSALLEM MICHAEL A Director Jan 05 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Jan 05 07:19 PM MUSSALLEM MICHAEL A Director Jan 05 '24 Sale 72.98 29,350 2,142,089 4,486 Jan 05 07:19 PM Ullem Scott B. CVP, Chief Financial Officer Dec 29 '23 Option Exercise 36.75 14,510 533,242 33,758 Dec 29 04:25 PM Ullem Scott B. CVP, Chief Financial Officer Dec 29 '23 Sale 76.55 14,510 1,110,794 19,248 Dec 29 04:25 PM Chopra Daveen CVP, TMTT Dec 15 '23 Option Exercise 59.26 7,000 414,797 30,950 Dec 15 05:22 PM Chopra Daveen CVP, TMTT Dec 15 '23 Sale 78.25 7,000 547,724 23,950 Dec 15 05:22 PM MUSSALLEM MICHAEL A Director Dec 13 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Dec 13 07:04 PM Wood Larry L Global President TAVR & Surg Dec 13 '23 Option Exercise 45.28 8,658 392,006 222,452 Dec 13 07:04 PM BOBO DONALD E JR CVP,Strategy/Corp Development Dec 13 '23 Option Exercise 36.75 8,000 294,000 47,503 Dec 13 07:04 PM MUSSALLEM MICHAEL A Director Dec 13 '23 Sale 74.62 29,350 2,190,043 4,486 Dec 13 07:04 PM Wood Larry L Global President TAVR & Surg Dec 13 '23 Sale 71.86 8,658 622,164 213,794 Dec 13 07:04 PM BOBO DONALD E JR CVP,Strategy/Corp Development Dec 13 '23 Sale 71.86 8,000 574,880 39,503 Dec 13 07:04 PM Chopra Daveen CVP, TMTT Dec 06 '23 Option Exercise 59.26 3,500 207,398 27,450 Dec 06 05:01 PM Chopra Daveen CVP, TMTT Dec 06 '23 Sale 70.00 3,500 245,006 23,950 Dec 06 05:01 PM Wood Larry L Global President TAVR & Surg Nov 13 '23 Option Exercise 45.28 8,660 392,096 222,454 Nov 13 05:21 PM BOBO DONALD E JR CVP,Strategy/Corp Development Nov 13 '23 Option Exercise 36.75 6,000 220,500 45,503 Nov 13 05:21 PM Wood Larry L Global President TAVR & Surg Nov 13 '23 Sale 65.30 8,660 565,460 213,794 Nov 13 05:21 PM BOBO DONALD E JR CVP,Strategy/Corp Development Nov 13 '23 Sale 65.30 6,000 391,780 39,503 Nov 13 05:21 PM MUSSALLEM MICHAEL A Director Nov 03 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Nov 06 06:33 PM MUSSALLEM MICHAEL A Director Nov 03 '23 Sale 67.18 29,350 1,971,733 4,486 Nov 06 06:33 PM Ullem Scott B. CVP, Chief Financial Officer Oct 31 '23 Option Exercise 36.75 7,255 266,621 26,503 Oct 31 05:22 PM Ullem Scott B. CVP, Chief Financial Officer Oct 31 '23 Sale 62.66 7,255 454,569 19,248 Oct 31 05:22 PM Wood Larry L Global President TAVR & Surg Oct 13 '23 Option Exercise 45.28 8,660 392,096 222,454 Oct 13 05:02 PM BOBO DONALD E JR CVP,Strategy/Corp Development Oct 13 '23 Option Exercise 36.75 5,000 183,750 44,503 Oct 13 05:01 PM Wood Larry L Global President TAVR & Surg Oct 13 '23 Sale 70.00 8,660 606,198 213,794 Oct 13 05:02 PM BOBO DONALD E JR CVP,Strategy/Corp Development Oct 13 '23 Sale 69.98 5,000 349,909 39,503 Oct 13 05:01 PM Szyman Catherine M. CVP, Critical Care Oct 10 '23 Option Exercise 36.75 5,000 183,750 39,814 Oct 10 06:23 PM Szyman Catherine M. CVP, Critical Care Oct 10 '23 Sale 72.68 5,000 363,400 34,814 Oct 10 06:23 PM Chopra Daveen CVP, TMTT Oct 03 '23 Option Exercise 59.26 8,500 503,682 32,450 Oct 03 04:58 PM Chopra Daveen CVP, TMTT Oct 03 '23 Sale 70.00 8,500 595,000 23,950 Oct 03 04:58 PM MUSSALLEM MICHAEL A Director Oct 02 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Oct 02 06:51 PM MUSSALLEM MICHAEL A Director Oct 02 '23 Sale 68.84 29,350 2,020,454 4,486 Oct 02 06:51 PM Ullem Scott B. CVP, Chief Financial Officer Sep 29 '23 Option Exercise 36.75 7,255 266,621 26,503 Sep 29 04:49 PM Ullem Scott B. CVP, Chief Financial Officer Sep 29 '23 Sale 69.54 7,255 504,527 19,248 Sep 29 04:49 PM Wood Larry L Global President TAVR & Surg Sep 14 '23 Option Exercise 45.28 8,660 392,096 222,454 Sep 14 08:00 PM BOBO DONALD E JR CVP,Strategy/Corp Development Sep 14 '23 Option Exercise 36.75 4,500 165,375 44,003 Sep 14 08:00 PM Wood Larry L Global President TAVR & Surg Sep 14 '23 Sale 73.63 8,660 637,615 213,794 Sep 14 08:00 PM BOBO DONALD E JR CVP,Strategy/Corp Development Sep 14 '23 Sale 73.71 4,500 331,695 39,503 Sep 14 08:00 PM Szyman Catherine M. CVP, Critical Care Sep 08 '23 Option Exercise 36.75 5,000 183,750 39,814 Sep 08 05:29 PM Szyman Catherine M. CVP, Critical Care Sep 08 '23 Sale 76.00 5,000 380,000 34,814 Sep 08 05:29 PM Chopra Daveen CVP, TMTT Sep 06 '23 Option Exercise 59.26 8,500 503,682 32,450 Sep 06 05:09 PM Chopra Daveen CVP, TMTT Sep 06 '23 Sale 76.07 8,500 646,609 23,950 Sep 06 05:09 PM MUSSALLEM MICHAEL A Director Sep 05 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Sep 05 07:08 PM MUSSALLEM MICHAEL A Director Sep 05 '23 Sale 75.86 29,350 2,226,491 4,486 Sep 05 07:08 PM Ullem Scott B. CVP, Chief Financial Officer Aug 31 '23 Option Exercise 36.75 7,255 266,621 26,503 Aug 31 05:34 PM Ullem Scott B. CVP, Chief Financial Officer Aug 31 '23 Sale 77.79 7,255 564,366 19,248 Aug 31 05:34 PM Chopra Daveen CVP, TMTT Aug 29 '23 Sale 76.69 1,500 115,040 23,950 Aug 29 05:31 PM Wood Larry L Global President TAVR & Surg Aug 14 '23 Option Exercise 45.28 6,421 290,722 220,215 Aug 14 06:02 PM BOBO DONALD E JR CVP,Strategy/Corp Development Aug 14 '23 Option Exercise 36.75 4,500 165,375 44,003 Aug 14 06:02 PM Wood Larry L Global President TAVR & Surg Aug 14 '23 Sale 79.30 6,421 509,185 213,794 Aug 14 06:02 PM BOBO DONALD E JR CVP,Strategy/Corp Development Aug 14 '23 Sale 79.30 4,500 356,850 39,503 Aug 14 06:02 PM STONE HEISZ LESLIE Director Aug 10 '23 Sale 78.87 3,303 260,509 26,980 Aug 10 05:48 PM Szyman Catherine M. CVP, Critical Care Aug 09 '23 Option Exercise 36.75 5,000 183,750 39,814 Aug 09 05:44 PM Szyman Catherine M. CVP, Critical Care Aug 09 '23 Sale 78.64 5,000 393,185 34,814 Aug 09 05:44 PM
Index -
P/E 12.67
EPS (ttm) 4.65
Insider Own 0.32%
Shs Outstand 115.90M
Perf Week 3.17%
Market Cap 6.82B
Forward P/E 7.10
EPS next Y 8.30
Insider Trans -26.17%
Shs Float 115.53M
Perf Month -0.24%
Income 562.00M
PEG 1.33
EPS next Q 1.91
Inst Own 95.60%
Short Float 3.41%
Perf Quarter -10.19%
Sales 12.46B
P/S 0.55
EPS this Y 0.76%
Inst Trans -3.59%
Short Ratio 3.14
Perf Half Y 5.54%
Book/sh 28.69
P/B 2.05
EPS next Y 10.95%
ROA 3.45%
Short Interest 3.94M
Perf Year 8.90%
Cash/sh 4.37
P/C 13.46
EPS next 5Y 9.50%
ROE 17.06%
52W Range 53.83 - 69.93
Perf YTD -12.66%
Dividend Est. 0.87 (1.47%)
P/FCF 6.95
EPS past 5Y 6.18%
ROI 4.47%
52W High -15.84%
Beta 1.18
Dividend TTM 1.05 (1.78%)
Quick Ratio 0.95
Sales past 5Y 11.00%
Gross Margin 16.24%
52W Low 9.34%
ATR (14) 1.10
Dividend Ex-Date Feb 29, 2024
Current Ratio 1.67
EPS Y/Y TTM -19.17%
Oper. Margin 9.14%
RSI (14) 56.67
Volatility 1.74% 1.80%
Employees 44000
Debt/Eq 2.82
Sales Y/Y TTM -10.91%
Profit Margin 4.51%
Recom 2.25
Target Price 69.78
Option/Short Yes / Yes
LT Debt/Eq 2.78
EPS Q/Q -41.09%
Payout 20.20%
Rel Volume 0.50
Prev Close 58.38
Sales Surprise -4.61%
EPS Surprise -6.86%
Sales Q/Q -6.76%
Earnings May 09 BMO
Avg Volume 1.25M
Price 58.86
SMA20 2.55%
SMA50 0.46%
SMA200 -4.71%
Trades
Volume 632,739
Change 0.82%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-16-24 Downgrade
Robert W. Baird
Outperform → Neutral
$68 → $65
Mar-27-24 Downgrade
Truist
Buy → Hold
$75 → $68
Mar-15-24 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$72 → $62
Mar-01-24 Initiated
Wolfe Research
Peer Perform
Jan-16-24 Resumed
UBS
Buy
$89
Oct-20-23 Resumed
Raymond James
Mkt Perform
May-24-23 Upgrade
Truist
Hold → Buy
$69 → $73
Jan-05-23 Downgrade
Truist
Buy → Hold
$70
Jul-20-22 Upgrade
Credit Suisse
Neutral → Outperform
$78
Jan-28-22 Resumed
Credit Suisse
Neutral
Nov-24-21 Initiated
Raymond James
Mkt Perform
Oct-13-21 Initiated
Mizuho
Neutral
$70
Sep-14-21 Initiated
Truist
Buy
$85
Apr-09-21 Initiated
Goldman
Buy
$75
Oct-14-20 Initiated
Seaport Global Securities
Buy
$71
Sep-17-20 Initiated
UBS
Buy
$70
Jul-13-20 Resumed
Jefferies
Buy
$57
Feb-13-20 Initiated
Credit Suisse
Outperform
$62
Sep-25-19 Upgrade
BofA/Merrill
Neutral → Buy
$51
Aug-22-19 Resumed
Goldman
Buy
$52
Show Previous Ratings
May-02-24 10:01AM
Apr-30-24 08:30AM
Apr-29-24 06:42AM
Apr-25-24 03:24AM
Apr-24-24 04:03PM
09:15AM
Loading…
Apr-17-24 09:15AM
07:15AM
Apr-11-24 05:30PM
06:50AM
Apr-10-24 03:56PM
Apr-09-24 10:48AM
10:14AM
Feb-24-24 07:06AM
Feb-13-24 09:45AM
Feb-09-24 05:02PM
10:29AM
Loading…
Feb-08-24 10:29AM
07:51AM
01:05AM
(Thomson Reuters StreetEvents)
Feb-07-24 05:50PM
09:30AM
08:35AM
07:36AM
07:33AM
(Associated Press Finance)
07:15AM
07:00AM
Feb-05-24 09:16AM
Feb-01-24 05:30PM
Jan-31-24 10:00AM
Jan-29-24 05:30PM
Jan-22-24 08:19AM
10:32AM
Loading…
Jan-16-24 10:32AM
Jan-11-24 05:30PM
08:15AM
Jan-10-24 04:47PM
08:46AM
Dec-07-23 03:05PM
Dec-01-23 11:04PM
Nov-28-23 09:39AM
Nov-23-23 05:04AM
Nov-20-23 09:32AM
07:57AM
Nov-17-23 12:09PM
03:43AM
(Thomson Reuters StreetEvents)
Nov-16-23 09:30AM
09:26AM
07:18AM
(Associated Press Finance)
07:00AM
06:45AM
Nov-14-23 11:11AM
08:00AM
Nov-13-23 11:49AM
Nov-09-23 10:00AM
Oct-27-23 10:51PM
Oct-20-23 12:45PM
(The Wall Street Journal)
Oct-19-23 04:30PM
Oct-14-23 06:21AM
Sep-22-23 11:31AM
Sep-20-23 09:00AM
Sep-15-23 11:30AM
Sep-13-23 09:47PM
Sep-12-23 09:00AM
Sep-08-23 11:30AM
08:24AM
08:12AM
08:00AM
Aug-29-23 12:24PM
Aug-21-23 01:03PM
Aug-16-23 01:29PM
Aug-15-23 09:00AM
Aug-10-23 04:04PM
11:14AM
01:11AM
(Thomson Reuters StreetEvents)
Aug-09-23 04:02PM
09:30AM
08:50AM
07:46AM
07:00AM
Aug-08-23 08:15AM
Aug-02-23 05:30PM
11:46AM
Jul-27-23 05:30PM
Jul-26-23 10:02AM
Jul-24-23 06:35PM
Jul-21-23 11:19AM
Jul-11-23 12:20PM
Jul-03-23 11:34AM
Jun-29-23 09:00AM
Jun-20-23 03:21PM
(Investor's Business Daily)
Jun-06-23 01:06PM
Jun-02-23 06:46PM
May-24-23 02:34PM
May-09-23 10:23AM
09:04AM
May-04-23 10:30AM
08:45AM
07:47AM
07:00AM
May-02-23 06:00PM
07:45AM
Apr-27-23 10:03AM
Berry Global Group, Inc. engages in the provision of non-woven products. It operates through the following segments: Consumer Packaging International, Consumer Packaging North America, Engineered Materials, and Health, Hygiene and Specialties. The Consumer Packaging International segment consists of products that primarily service non-North American markets. The Engineered Materials segment involves the manufacture of flexible products that service primarily North American and European markets. The Health, Hygiene and Specialties segment refers to services to global markets. The company was founded in 1967 and is headquartered in Evansville, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Steele Robert Allan Director Feb 24 '24 Sale 58.93 14,000 825,020 4,728 Feb 23 04:34 PM Steele Robert Allan Director Feb 21 '24 Option Exercise 28.75 14,000 402,500 18,728 Feb 23 04:34 PM FOSTER JONATHAN F Director Feb 12 '24 Buy 58.49 1,000 58,490 5,728 Feb 13 01:58 PM Kwilinski Kevin J. Chief Executive Officer Feb 09 '24 Buy 57.44 2,000 114,880 2,000 Feb 09 02:52 PM Bayh Evan Director Feb 09 '24 Buy 57.83 1,000 57,830 30,228 Feb 09 02:56 PM Thomas Peter T Director Feb 08 '24 Buy 56.00 2,000 112,000 2,000 Feb 09 03:03 PM Till James Controller Dec 05 '23 Option Exercise 29.59 11,903 352,210 11,903 Dec 06 04:36 PM Till James Controller Dec 05 '23 Sale 65.32 11,903 777,504 0 Dec 06 04:36 PM Miles Mark W Chief Financial Officer Dec 04 '23 Option Exercise 28.75 40,000 1,150,000 124,502 Dec 06 04:40 PM Till James Controller Dec 04 '23 Option Exercise 29.59 20,097 594,670 20,097 Dec 06 04:36 PM Miles Mark W Chief Financial Officer Dec 04 '23 Sale 66.29 40,000 2,651,600 84,502 Dec 06 04:40 PM Till James Controller Dec 04 '23 Sale 66.81 20,097 1,342,681 0 Dec 06 04:36 PM RICKERTSEN CARL J Director Nov 29 '23 Option Exercise 47.29 18,951 896,205 14,258 Dec 01 04:58 PM RICKERTSEN CARL J Director Nov 29 '23 Sale 64.96 18,951 1,231,057 2,758 Dec 01 04:58 PM RICKERTSEN CARL J Director Nov 24 '23 Option Exercise 49.56 7,849 388,964 10,058 Nov 28 04:50 PM RICKERTSEN CARL J Director Nov 24 '23 Sale 64.81 7,849 508,694 2,758 Nov 28 04:50 PM Greene Jason K. Chief Legal Officer Nov 21 '23 Option Exercise 28.75 24,480 703,800 24,730 Nov 22 05:00 PM RICKERTSEN CARL J Director Nov 21 '23 Option Exercise 49.53 200 9,906 200 Nov 22 04:50 PM Greene Jason K. Chief Legal Officer Nov 21 '23 Sale 64.62 24,480 1,581,898 250 Nov 22 05:00 PM RICKERTSEN CARL J Director Nov 21 '23 Sale 65.00 200 13,000 0 Nov 22 04:50 PM Bayh Evan Director Oct 27 '23 Option Exercise 21.00 14,000 294,000 41,258 Oct 27 05:19 PM Bayh Evan Director Oct 27 '23 Sale 54.57 14,000 763,980 27,258 Oct 27 05:19 PM Miles Mark W Chief Financial Officer Aug 15 '23 Option Exercise 21.00 50,000 1,050,000 115,456 Aug 17 04:46 PM Miles Mark W Chief Financial Officer Aug 15 '23 Sale 65.76 30,954 2,035,535 84,502 Aug 17 04:46 PM Norman William J President Aug 11 '23 Option Exercise 28.75 9,000 258,750 9,000 Aug 14 04:52 PM Norman William J President Aug 11 '23 Sale 66.48 9,000 598,320 0 Aug 14 04:52 PM Norman William J President Aug 10 '23 Option Exercise 28.75 30,000 862,500 30,000 Aug 14 04:52 PM Norman William J President Aug 10 '23 Sale 66.11 30,000 1,983,300 0 Aug 14 04:52 PM Greene Jason K. Chief Legal Officer Jul 25 '23 Option Exercise 28.75 520 14,950 770 Jul 26 05:11 PM Greene Jason K. Chief Legal Officer Jul 25 '23 Sale 68.01 520 35,365 250 Jul 26 05:11 PM Hill Michael Edward President Jul 18 '23 Option Exercise 29.59 28,369 839,439 28,369 Jul 19 05:06 PM Hill Michael Edward President Jul 18 '23 Sale 66.57 28,369 1,888,524 0 Jul 19 05:06 PM Hill Michael Edward President Jul 12 '23 Option Exercise 29.59 4 107 3,631 Jul 13 05:06 PM Hill Michael Edward President Jul 12 '23 Sale 66.52 3,631 241,534 0 Jul 13 05:06 PM Hill Michael Edward President Jun 16 '23 Option Exercise 25.36 24,910 631,610 14,000 Jun 20 05:23 PM Hill Michael Edward President Jun 16 '23 Sale 64.13 24,910 1,597,478 0 Jun 20 05:23 PM Hill Michael Edward President Jun 14 '23 Option Exercise 21.00 1,090 22,890 1,090 Jun 15 05:04 PM Hill Michael Edward President Jun 14 '23 Sale 63.51 1,090 69,226 0 Jun 15 05:04 PM Miles Mark W Chief Financial Officer Jun 06 '23 Option Exercise 21.00 50,000 1,050,000 97,058 Jun 07 05:25 PM Miles Mark W Chief Financial Officer Jun 06 '23 Sale 61.34 31,602 1,938,467 65,456 Jun 07 05:25 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite